MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2025.09.005

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025

Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model.

Lanzillotta Marco, Macinga Peter, Poulsen Jakob L, Vinge-Holmquist Olof, Demirci A Fatih, Tacelli Matteo, Backhus Johanna, Algül Hana, Descourvieres Clémence, Kiriukova Mariia, Goni Elisabetta, Hollenbach Marcus, Miksch Rainer C, Kunovsky Lumir, Vujasinovic Miroslav, Nikolic Sara, Dickerson Luke, Hirth Michael, Neurath Markus F, Zumblick Malte, Vila Josephine, Jalal Mustafa, Beyer Georg, Frost Fabian, Carrara Silvia, Kala Zdenek, Jabandziev Petr, Sisman Gurhan, Akyuz Filiz, Capurso Gabriele, Falconi Massimo, Arlt Alexander, Vleggaar Frank P, Barresi Luca, Greenhalf Bill, Czakó László, Hegyi Peter, Hopper Andrew, Nayar Manu K, Gress Thomas M, Vitali Francesco, Schneider Alexander, Halloran Chris M, Trna Jan, Okhlobystin Alexey V, Dagna Lorenzo, Cahen Djuna L, Bordin Dmitry, Rebours Vinciane, Mayerle Julia, Kahraman Alisan, Rasch Sebastian, Culver Emma, Kleger Alexander, Martínez-Moneo Emma, Hucl Tomas, Olesen Søren S, Bruno Marco J, Beuers Ulrich, Della-Torre Emanuel, Löhr J Matthias, Rosendahl Jonas, Overbeek Kasper A, PrescrAIP Study Group

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND & AIMS: Type 1 autoimmune pancreatitis (AIP) is a relapsing remitting disorder that often requires multiple treatment courses. Our aims were to assess the efficacy of maintenance treatment in preventing relapse and to develop the PrescrAIP risk score predicting relapse risk and the benefit of maintenance treatment.

METHODS

We retrospectively analyzed patients meeting international diagnostic criteria for type 1 AIP who reached partial or complete remission after initial treatment. The primary outcome was disease relapse, defined as recurrence of symptoms and/or radiologic findings. We developed a multivariable prediction model using Cox proportional hazards regression, performed internal and internal-external validation, and built a predictive nomogram.

RESULTS

We included 577 patients (68% male). During a median follow-up of 34 months (interquartile range, 13-69 months), we observed 154 relapses. The overall 3-year relapse risk was 28% (95% confidence interval [CI], 24%-32%), lower in patients receiving maintenance treatment than in those without (22% vs 35%; P < .001). The final PrescrAIP model incorporated protective factors (maintenance treatment, prior surgery, focal mass, female sex) and risk factors (biliary involvement, other organ involvement, IgG4 elevation, allergy, jaundice, acute pancreatitis). The model showed moderate discrimination (Concordance index, 0.69) and good calibration. Internal-external validation yielded Concordance index values ranging from 0.64 to 0.71. Maintenance treatment significantly reduced relapse in patients with a PrescrAIP score >155, but not in those with lower scores.

CONCLUSIONS

Maintenance therapy reduced relapse only in patients at high relapse risk. Once externally validated, the PrescrAIP score may guide personalized maintenance treatment decisions.

Для цитирования: Lanzillotta Marco, Macinga Peter, Poulsen Jakob L, Vinge-Holmquist Olof, Demirci A Fatih, Tacelli Matteo, Backhus Johanna, Algül Hana, Descourvieres Clémence, Kiriukova Mariia, Goni Elisabetta, Hollenbach Marcus, Miksch Rainer C, Kunovsky Lumir, Vujasinovic Miroslav, Nikolic Sara, Dickerson Luke, Hirth Michael, Neurath Markus F, Zumblick Malte, Vila Josephine, Jalal Mustafa, Beyer Georg, Frost Fabian, Carrara Silvia, Kala Zdenek, Jabandziev Petr, Sisman Gurhan, Akyuz Filiz, Capurso Gabriele, Falconi Massimo, Arlt Alexander, Vleggaar Frank P, Barresi Luca, Greenhalf Bill, Czakó László, Hegyi Peter, Hopper Andrew, Nayar Manu K, Gress Thomas M, Vitali Francesco, Schneider Alexander, Halloran Chris M, Trna Jan, Okhlobystin Alexey V, Dagna Lorenzo, Cahen Djuna L, Bordin Dmitry, Rebours Vinciane, Mayerle Julia, Kahraman Alisan, Rasch Sebastian, Culver Emma, Kleger Alexander, Martínez-Moneo Emma, Hucl Tomas, Olesen Søren S, Bruno Marco J, Beuers Ulrich, Della-Torre Emanuel, Löhr J Matthias, Rosendahl Jonas, Overbeek Kasper A, PrescrAIP Study Group. Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2025. DOI: 10.1016/j.cgh.2025.09.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.